Abstract
Though a variety of immune-related adverse events of immune checkpoint
inhibitors (ICIs) including bullous pemphigoid have been reported,
non-bullous pemphigoid (NBP) associated with ICI therapy was scarcely
reported. We present a case of NBP with a long latent disease course
without diagnosis during nivolumab, an ICI therapy.